Dr. Reddy’s Laboratories announced the launch of Memantine HCI Tablets, the generic version of Actavis’ Namenda.

Namenda is an NMDA receptor antagonist approved for the treatment of moderate-to-severe dementia of the Alzheimer’s type. It is postulated to exert its therapeutic effect through its action as a low to moderate affinity uncompetitive (open-channel) NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels.

RELATED: Alzheimer’s Drug Won’t Be Discontinued After All

Memantine HCI Tablets are available as 5mg strength tablets in 60-count bottles and 10mg strength tablets in 60- and 500-count bottles.

For more information call (866) 733-3952 or visit DrReddys.com.